Plain-English translation of NCT07561255 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a digital health app called Axia designed to help people with ankylosing spondylitis (a type of spine arthritis). The study wants to learn whether giving people immediate access to try the app for 14 days — before their insurance approval comes through — makes them more likely to use it and find it helpful compared to the standard enrollment process.
Many people with ankylosing spondylitis could benefit from digital tools that support their care, but we don't know the best way to get patients started with these apps. This trial is testing whether removing barriers to early access helps more people actually use and stick with the treatment.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups: either you'll get immediate 14-day trial access to the Axia app right away, or you'll follow the standard enrollment process and wait for your insurance approval code. Over 12 weeks, you'll use the app as part of your regular care and optionally answer brief feedback questions at weeks 6 and 12 about your experience with it. The researchers will track how many people activate the app and whether they find it useful.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Germany